In describingthe clinical, biochemical, and family findings in five children with porphyria, we examine initial treatments and, where appropriate, the effectiveness of longterm therapy. We note that porphyria diagnosis, particularly in childhood, relies heavily on specialist laboratory investigations.Because disease expression in some porphyrias requires exposure to precipitating factors, it may be prevented or delayed by their avoidance. 
In describingthe clinical, biochemical, and family findings in five children with porphyria, we examine initial treatments and, where appropriate, the effectiveness of longterm therapy. We note that porphyria diagnosis, particularly in childhood, relies heavily on specialist laboratory investigations.Because disease expression in some porphyrias requires exposure to precipitating factors, it may be prevented or delayed by their avoidance. Patients may have overt, subclinical, or latent disease; manifestation ofporphyria is usually delayed until after puberty. This had led, until recently, to the belief that porphyria was essentially an adult disease. It is now much more widely appreciated that it is not the disease but merely the diagnosis that is so rare in childhood. Indeed, the much lower incidence of overt 1 
Materialsand Methods
Blood was collected into a heparinized container and an aliquot was centrifuged for assay of the plasma. Leukocytes were isolated by standard procedures (1 Table 2 . These results were diagnostic of familial (type II) PCT and excluded other types of porphyria.
In addition to advising protection from sun exposure, treatment was commenced in March 1988 with oral chioroquine, 12.5 mg twice a week. Despite an inimediate and dramatic increase in urinary porphyrin excretion, which persisted over several months, the young girl showed an improvement in her well-being and a reduction of the frequency of blistering lesions on the back ofthe hands and face; however, there were residual milia in these areas. She also had persistent skin fragility secondary to trauma, particularly noticeable on her legs. When reviewed in December 1988, the patient was free of blisters and erosions and the scars had faded considerably; since then, she has been asymptomatic. 
Patient3
The porphyrin precursor, PBG, was grossly increased at postmortem examination of the 70-year-old paternal grandmother of patient 3. An acute porphyria was diagnosed on the basis of the increased concentration of PBG, qualitatively determined by a referring laboratory using a simple screening test. Her four clinically well grandchildren were subsequently investigated by the same referring laboratory and results for urine, blood, and fecal porphyrin tests were all reported to be normal. As was the case with the grandmother, no tests for enzyme insufficiency were performed. As a precautionary measure, before administering anesthesia for a minor surgical procedure to the 6-yearold granddaughter (patient 3), blood, urine, and feces were again collected and sent to our laboratory for more comprehensive porphyrin investigations.
Records from an operation under general anesthesia 3 years before had noted the patient was "slow to wake up," with "3#{189} hours in recovery." The considerably reduced PBGD activity with normal concentrations for porphyrin, PBG, and ALA were consistent with this patient's being an asymptomatic gene carrier for AlP (Tables 1 and 2 
Patient5
Medical and biochemical evaluation was sought in 
Discussion
A deficiency in enzyme activity was established only after the analysis (in duplicate) of at least two different blood specimens collected several weeks apart. This was done to counter any effect on enzyme activity from viral and bacterial infections (22-24). Also, a complete drug history was gathered and a toxicology screen performed to allow drug therapy, particularly anticonvulsant therapy, to be excluded as the cause of abnormal enzyme activity (25). In establishing a reference range for each enzyme, we determined that the mean enzyme activity, as well as the lower and upper range limit, was relatively constant and unrelated to age and sex.
Because patient 1 has familial PCT, we anticipate that long-term chioroquine therapy will be necessary. This contrasts with one of the few reported cases of the In investigating patient 1, we identified another miportant distinguishing aspect of the familial and the sporadic condition. Our 18 patients, of all ages, who have tested positive for familial PCT have always had normal y-glutainyltransferase activities at diagnosis; contrast this with our 87 patients with sporadic PCT, whose plasma y-glutamyltransferase values have never been <3.5 times the upper normal range at initial diagnosis. The determination ofthis liver enzyme is less technically demanding than the assay of uroporphyrinogen decarboxylase and is very useful in checking the familial or sporadic status of a PCT condition. gnus HC in children (40-42) , whose deficiency of COOX is severe (< 10% ofnormal values) Importantly, urinary coproporphyrin concentrations and its isomer 1:111ratios, which when increased are said to serve as a sensitive indicator for the hepatic complication of protoporphyria, remain normal in patient 4. She will continue to be very closely monitored for hepatobiliary disease.
In conclusion, descriptions of porphyrias in children are rare and usually limited to single reports with no follow-up. In outlining the cases above, we have demonstrated the value of providing a comprehensive porphyun service within a pediatric institution. Surely such institutions are able not only to recognise the existence of overt childhood porphyrias, but also to screen for latent and subclinical carriers. Further, through the ease of monitoring a child's progress several years after initial diagnosis and their better compliance with thorapy relative to adults, young patients can be given a prognosis based on historical information, not speculation. The low level ofdllnical expression despite reduced enzyme activities is a striking feature of juvenile perphyrias in our experience.
Early biochemical diagnosis with the avoidance of porphyrinogenic factors is very effective treatment. 
